Insights

Access our latest insights & resources

Filters

Research Type: Fundamental

European Banks: Tougher 2024 Amid Easing Interest Rate Tailwind

European Banks: Tougher 2024 Amid Easing Interest Rate Tailwind

Fundamental, Research
European banks are expected to perform well in Q4 2023 due...
Read more
Alphabet Dec-Q Preview – Will Cloud Growth Stabilize After Disappointing in Q3?

Alphabet Dec-Q Preview – Will Cloud Growth Stabilize After Disappointing in Q3?

Fundamental, Research
Alphabet Inc. (GOOGL) will release Q4 results on January 30...
Read more
Holiday Sales Expectations for Retailers (ex. Auto)

Holiday Sales Expectations for Retailers (ex. Auto)

Fundamental, Research
During the holiday season, e-commerce or non-store retail...
Read more
Data Center REITs: A Differentiated Play on AI

Data Center REITs: A Differentiated Play on AI

Fundamental, Research, Video
The release of ChatGPT in late 2022 pushed the markets into an AI...
Read more
Global U.S. Banks: Q4 2023 Earnings Preview

Global U.S. Banks: Q4 2023 Earnings Preview

Fundamental, Research
Global US banks may have weak Q4 comps.
Read more
2024 Technology Hardware/Storage Outlook

2024 Technology Hardware/Storage Outlook

Fundamental, Research
The technology hardware industry has faced numerous challenges in the...
Read more
Drug Distributors: Prescription Volumes, New Therapies Powering Higher Stock Prices

Drug Distributors: Prescription Volumes, New Therapies Powering Higher Stock Prices

Fundamental, Research
Drug distributors MCK, COR, and CAH have been performing significantly...
Read more
European Maritime Logistics: Overcapacity and Subdued Demand Sink Freight Rates

European Maritime Logistics: Overcapacity and Subdued Demand Sink Freight Rates

Fundamental, Research
Maritime logistics are grappling with a new reality characterized by plummeting market freight...
Read more
Consumer Staples: Risks From Anti-Obesity Medications Likely Overblown

Consumer Staples: Risks From Anti-Obesity Medications Likely Overblown

Fundamental, Research
Anti-obesity medications (AOMs), including glucagon-like peptide-1 (GLP-1) agonists...
Read more
Amazon: $7+ EPS by 2025 Could Be the Next Catalyst

Amazon: $7+ EPS by 2025 Could Be the Next Catalyst

Fundamental, Research
Wall Street has historically valued AMZN shares using nontraditional relative valuation metrics.
Read more